Another week of bad week in the markets, and I was steeling myself for the fourth straight week cueing those sad, sad, trombones… But… I should have looked at the spread sheet.
Yah, sure, the NASDAQ Composite shed -2.7% for the week, typical for the other broad indices as well. But the Biotech indices were good news, the S&P Biotech Index up +3.6%. And this seemed a pretty broad move for the sector, with 116 out of the 190 stocks chosen by the contest participants in the Black.
Looking at the individual entries we see some very good news. And it is, in fact, real news, not someone at Motley Fool talking a stock up.
Instead, finally big moves from stocks as a result of a science event:
BIOA-B.ST was the top stock for the last week, doubling. At first I thought, oh, another reverse stock split. But 2 for 1 is really not a likely split. What I found was:
Lecanemab phase 3 Clarity AD study in early Alzheimer’s disease meets primary and all key secondary endpoints with high statistical significance
marketwatch.com
This was enough to move BIOA-B.ST up to third place in YTD performance (+85%).And then also in second place, XFOR up +86%.X4 Pharma Highlights New Data Supporting Mavorixafor's Broad Potential In Chronic Neutropenia
HROW is up 51%, because a key product is hitting distribution.
As far as the rest, maybe it was just some end of the quarter enthusiasm. Some stocks *did* lose. Yep, there’s my old zombie friend GNCA.
Moving to the portfolio performance, we see an increase in the portfolio average of +2.4%. The median also up +1.7%. The best performing portfolio for the week, JFM WINTER up +28%! (No prize for guessing who was the sole investor in BIOA-B.ST among the contestants). HORESINALFALFA in third place for the week (+7.4%), which bumped them up to 7th in the YTD performance, the only change in the relative standings in the top 10, other than JACK HARTMANN’s return, with only a one week absence.
With the end of the quarter, this contest is moving into the home stretch. Another three months to go. Still lots of opportunities for interesting results. Stay tuned.
|
Report Time Ranges
|
|
|
From
|
To
|
Recent
|
9/23/22
|
9/30/22
|
YTD
|
12/31/21
|
Index Performance
|
|
Symbol
|
Recent
|
YTD
|
|
^IXIC
|
-2.69%
|
-32.40%
|
^NBI
|
2.05%
|
-20.33%
|
^SPSIBI
|
3.62%
|
-29.05%
|
Share Performance
|
Recent
|
YTD
|
Top 5
|
Bottom 5
|
Top 5
|
Bottom 5
|
BIOA-B.ST
|
207.240%
|
GNCA
|
-22.164%
|
OPTN
|
125.93%
|
GNCA
|
-98.98%
|
XFOR
|
85.829%
|
OCUL
|
-21.550%
|
CBIO
|
109.71%
|
VLON
|
-95.23%
|
HROW
|
51.064%
|
ACHL
|
-20.423%
|
BIOA-B.ST
|
85.63%
|
PTE
|
-94.07%
|
BIIB
|
34.998%
|
STSA
|
-18.033%
|
FENC
|
84.09%
|
RNLX
|
-91.95%
|
PLXP
|
24.712%
|
PRDS
|
-14.747%
|
RVNC
|
65.44%
|
PLXP
|
-91.89%
|
|
Top 10 Portfolio YTD
|
YTD(Portfolio - SPSIBI)
|
Rec
|
Rec(Port. - SPSIBI)
|
DIEGOSAN
|
-3.88%
|
25.18%
|
0.514%
|
-3.110%
|
DEW DILIGENCE
|
-10.91%
|
18.14%
|
3.142%
|
-0.482%
|
TECHNETIUM
|
-15.14%
|
13.92%
|
3.580%
|
-0.044%
|
BIOSCIENTISTSA
|
-24.14%
|
4.92%
|
1.802%
|
-1.823%
|
BRENDAN_49
|
-26.80%
|
2.26%
|
-0.281%
|
-3.906%
|
GENEGURU
|
-26.99%
|
2.06%
|
1.632%
|
-1.993%
|
HORSEINALFALFA
|
-27.11%
|
1.94%
|
7.356%
|
3.731%
|
ROCKY9
|
-27.35%
|
1.70%
|
2.030%
|
-1.595%
|
A.J. MULLEN
|
-29.01%
|
0.05%
|
0.682%
|
-2.942%
|
JACK HARTMANN
|
-33.27%
|
-4.22%
|
3.776%
|
0.152%
|
Average and Median Portfolio Performance
|
|
Avg Recent
|
Avg YTD
|
Median Recent
|
Median YTD
|
|
$1,342
|
-39.42%
|
ETHAN H
|
$1,079
|
JFM WINTER
|
-38.57%
|
2.41%
|
GENEGURU
|
1.678%
|
|
